Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention
Cited by 52
Related Papers
TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway
|Journal of Experimental & Clinical Cancer Research|2018|155
Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma
|EMBO Molecular Medicine|2019|82
In vivo and in vitro Approach to Anti-arthritic and Anti-inflammatory Effect of Crocetin by Alteration of Nuclear Factor-E2-Related Factor 2/hem Oxygenase (HO)-1 and NF-κB Expression
|Frontiers in Pharmacology|2018|72
RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation
|Oncogene|2019|64
Hsa_circ_0128846 promotes tumorigenesis of colorectal cancer by sponging hsa‐miR‐1184 and releasing AJUBA and inactivating Hippo/YAP signalling
|Journal of Cellular and Molecular Medicine|2020|52